Header Logo

Paul Jeffrey

Concepts (84)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
11
2019
362
2.480
 Why?
Medication Therapy Management
3
2018
21
1.530
 Why?
Antiviral Agents
4
2018
324
1.410
 Why?
Analgesics, Opioid
4
2019
536
1.370
 Why?
Pain
3
2019
406
1.190
 Why?
Practice Patterns, Physicians'
5
2019
712
1.010
 Why?
Hepatitis C
2
2016
151
0.880
 Why?
Hepatitis C, Chronic
2
2018
88
0.670
 Why?
Drug Utilization Review
2
2017
52
0.640
 Why?
Drug and Narcotic Control
2
2017
28
0.640
 Why?
Uridine Monophosphate
1
2018
9
0.580
 Why?
Fluorenes
1
2018
14
0.580
 Why?
Benzimidazoles
1
2018
54
0.560
 Why?
Psychotropic Drugs
1
2018
84
0.550
 Why?
Hydrocodone
1
2017
7
0.540
 Why?
Drug Prescriptions
1
2018
168
0.520
 Why?
Hepacivirus
1
2018
141
0.520
 Why?
Progesterone
1
2017
163
0.520
 Why?
United States
11
2019
7843
0.500
 Why?
Premature Birth
1
2017
112
0.490
 Why?
Medication Adherence
1
2017
203
0.490
 Why?
Prescription Drug Misuse
1
2014
21
0.430
 Why?
State Government
1
2014
32
0.430
 Why?
Retrospective Studies
7
2018
6659
0.390
 Why?
Health Services Accessibility
1
2016
564
0.350
 Why?
Mental Disorders
1
2018
791
0.340
 Why?
Opioid-Related Disorders
2
2014
507
0.320
 Why?
Drug Combinations
3
2019
165
0.310
 Why?
Cost Savings
2
2016
54
0.230
 Why?
Drug Costs
2
2016
56
0.230
 Why?
Young Adult
4
2019
4695
0.220
 Why?
Adult
6
2019
16826
0.220
 Why?
Cost-Benefit Analysis
2
2017
311
0.220
 Why?
Insurance, Pharmaceutical Services
2
2014
19
0.220
 Why?
Adolescent
4
2019
6245
0.220
 Why?
Program Evaluation
2
2018
487
0.210
 Why?
Pharmacists
2
2016
127
0.210
 Why?
Female
7
2019
32883
0.190
 Why?
Humans
11
2019
63449
0.190
 Why?
Massachusetts
2
2018
2075
0.190
 Why?
Sofosbuvir
2
2018
17
0.180
 Why?
Middle Aged
5
2019
17615
0.180
 Why?
Male
6
2019
29893
0.170
 Why?
Cohort Studies
2
2017
2570
0.170
 Why?
Treatment Outcome
3
2016
5680
0.160
 Why?
Chloride Channel Agonists
1
2019
3
0.160
 Why?
Aminophenols
1
2019
4
0.160
 Why?
Benzodioxoles
1
2019
13
0.160
 Why?
Aminopyridines
1
2019
32
0.160
 Why?
Quinolones
1
2019
29
0.160
 Why?
Sustained Virologic Response
1
2018
10
0.150
 Why?
Ribavirin
1
2018
23
0.150
 Why?
Cystic Fibrosis
1
2019
121
0.140
 Why?
Polypharmacy
1
2018
61
0.140
 Why?
Treatment Failure
1
2018
201
0.140
 Why?
Hydroxyprogesterones
1
2017
6
0.140
 Why?
Insurance, Health, Reimbursement
1
2017
42
0.140
 Why?
Controlled Substances
1
2017
5
0.140
 Why?
Viral Load
1
2018
231
0.140
 Why?
Drug Therapy, Combination
1
2018
465
0.130
 Why?
Dose-Response Relationship, Drug
1
2019
864
0.130
 Why?
Gestational Age
1
2017
189
0.130
 Why?
RNA, Viral
1
2018
276
0.130
 Why?
Psychiatry
1
2018
125
0.130
 Why?
Genotype
1
2018
663
0.120
 Why?
Insurance Claim Review
1
2016
76
0.120
 Why?
Evidence-Based Medicine
1
2018
462
0.120
 Why?
Pregnancy Outcome
1
2017
194
0.120
 Why?
Prescription Drug Diversion
1
2014
7
0.110
 Why?
Lung
1
2019
956
0.110
 Why?
Government Regulation
1
2014
41
0.110
 Why?
Drug Interactions
1
2014
127
0.110
 Why?
Managed Care Programs
1
2014
89
0.100
 Why?
Interdisciplinary Communication
1
2014
105
0.100
 Why?
Physician's Role
1
2014
124
0.100
 Why?
Cooperative Behavior
1
2014
222
0.100
 Why?
Health Policy
1
2014
192
0.090
 Why?
Child
2
2019
4526
0.090
 Why?
Pregnancy
1
2017
2335
0.080
 Why?
Time Factors
1
2014
3768
0.060
 Why?
Aged
1
2018
14449
0.050
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
76
0.040
 Why?
Ambulatory Care
1
2017
311
0.030
 Why?
Mutation
1
2019
2612
0.020
 Why?
Jeffrey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (84)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_